U.S. Markets closed

Aoxing Pharmaceutical Company, Inc. (AXN)

NYSE MKT - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.2750+0.0050 (+1.8519%)
At close: 3:32PM EDT
People also watch
CAPNCRMDPBMDCPHIAVEO
Full screen
Previous Close0.2700
Open0.2565
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2750 - 0.2799
52 Week Range0.2600 - 0.6900
Volume16,621
Avg. Volume69,857
Market Cap20.96M
Beta2.96
PE Ratio (TTM)-14.47
EPS (TTM)-0.02
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.00
Trade prices are not sourced from all markets
  • Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 26, 2017
    Capital Cube3 months ago

    Aoxing Pharmaceutical Co., Inc. :AXN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 26, 2017

    Categories: Yahoo FinanceGet free summary analysis Aoxing Pharmaceutical Co., Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Aoxing Pharmaceutical Co., Inc. – Pfizer Inc., Catalyst Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Impax Laboratories, Inc., Johnson & Johnson, Mylan N.V., Omeros Corporation, Amicus Therapeutics, Inc., ... Read more (Read more...)

  • Accesswire3 months ago

    Aoxing Pharmaceutical Reports Q3 Fiscal 2017 Financial Results

    FOSTER CITY, CA / ACCESSWIRE / May 15 , 2017 / Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) today announced that for the third quarter of fiscal year 2017, ended March 31, 2017, the Company reported ...

  • Associated Press3 months ago

    Aoxing posts 3Q profit

    The Shijiazhuang City, China-based company said it had net income of less than 1 cent on a per-share basis. The specialty pharmaceutical company posted revenue of $5.7 million in the period. The company's ...